Berry (BRY) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
4 Nov, 2025Executive summary
A merger is proposed where Berry will merge with a CRC subsidiary, becoming a wholly owned CRC subsidiary, with Berry shareholders receiving 0.0718 CRC shares per Berry share, subject to approval at a special meeting on December 15, 2025.
The Berry board unanimously recommends approval, citing strategic fit, financial accretion, and a 15% premium to Berry’s pre-announcement share price.
The merger is expected to close in Q1 2026, pending regulatory and shareholder approvals, with Berry shares delisted post-merger.
Voting matters and shareholder proposals
Shareholders will vote on: (1) the merger agreement, (2) a non-binding advisory vote on executive compensation related to the merger, and (3) potential adjournment of the meeting to solicit more votes if needed.
Approval of the merger requires a majority of outstanding Berry shares; abstentions and broker non-votes count as votes against.
The board recommends voting FOR all proposals.
Board of directors and corporate governance
Berry’s board conducted a multi-year strategic review, engaged advisors, and negotiated with multiple parties before agreeing to the CRC merger.
Post-merger, CRC’s current directors and officers are expected to remain in place.
The merger agreement includes customary governance and anti-takeover provisions.
Latest events from Berry
- Q2 saw $74M EBITDA, $19M free cash flow, and a $44M impairment-driven net loss.BRY
Q2 20241 Feb 2026 - Q3 2024 net income hit $70M, free cash flow rose, and debt was refinanced with a $545M loan.BRY
Q3 202415 Jan 2026 - 2024 saw strong EBITDA, stable output, and disciplined 2025 guidance with increased Utah focus.BRY
Q4 202425 Dec 2025 - All-stock merger forms California's top energy platform, targeting $80–$90M in synergies by 2026.BRY
M&A Announcement16 Dec 2025 - Annual meeting to vote on directors, pay, and auditor, highlighting strong 2024 results and ESG progress.BRY
Proxy Filing2 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify auditor on May 20, 2025.BRY
Proxy Filing2 Dec 2025 - Q1 2025 net loss from impairment, but strong cash flow and guidance reaffirmed.BRY
Q1 202525 Nov 2025 - Q2 2025 returned to profit with strong production, but H1 was impacted by lower prices and impairment.BRY
Q2 202524 Nov 2025 - Q3 2025 net loss of $26M, production down 4% YoY, $158M impairment, and CRC merger pending.BRY
Q3 20255 Nov 2025